Literature DB >> 8922751

Effect of Cu2+ on relaxations to the nitrergic neurotransmitter, NO and S-nitrosothiols in the rat gastric fundus.

J G De Man1, B Y De Winter, G E Boeckxstaens, A G Herman, P A Pelckmans.   

Abstract

1. The effects of addition of Cu2+ and chelation of Cu2+ were studied on relaxations in response to S-nitrosothiols and on relaxations to non-adrenergic non-cholinergic (NANC) nerve stimulation, nitric oxide (NO) and glyceryl trinitrate (GTN) in the rat gastric fundus. 2. The S-nitrosothiols S-nitroso-L-cysteine (NOCys, 1-300 nM), S-nitrosoglutathione (GSNO, 0.01-3 microM) and S-nitroso-N-acetyl-D,L-penicillamine (SNAP, 0.01-3 microM) induced concentration-dependent relaxations of the rat gastric fundus muscle strip. The relaxant potencies of the S-nitrosothiols were NOCys > SNAP > GSNO. Relaxations to NOCys were transient and comparable to those to NANC nerve stimulation and NO whereas relaxations to GSNO and SNAP were sustained. The relaxations to NOCys, GSNO and SNAP were significantly and concentration-dependently enhanced by CuSO4 (3-30 microM). The order of relaxant potency in the presence of CuSO4 was reversed to GSNO approximately SNAP > NOCys. 3. In the presence but not in the absence of 0.1 microM GSNO, CuSO4 (1 microM) induced a rapid and transient relaxation which was inhibited by the superoxide radical generator, pyrogallol (30 microM). CuCl2 but not FeSO4 mimicked the effect of CuSO4. 4. Electrical stimulation (0.5-8 Hz) of the rat gastric fundus strips induced frequency-dependent relaxations which were previously shown to be nitrergic in nature and which were not affected by CuSO4 (3-30 microM). Relaxations to NO (3-100 nM) and GTN (0.01-1 microM) were not affected by 3 and 10 microM CuSO4 but were inhibited by 30 microM CuSO4. 5. The Cu2+ chelator, bathocuproine (3-30 microM) significantly and concentration-dependently inhibited the relaxations to NOCys (0.01-3 microM), GSNO (0.01-10 microM) and SNAP (0.01-3 microM). The inhibitory effect of 10 microM bathocuproine was reversed by 3 microM CuSO4. 6. Bathocuproine (3-30 microM) had no effect on the relaxations to NANC nerve stimulation (0.5-8 Hz) or on the concentration-response curve to NO (0.01-0.3 microM), whereas relaxations to GTN (0.01-1 microM) were significantly inhibited by 30 microM bathocuproine. 7. From these results we conclude that relaxations to S-nitrosothiols and to nitrergic stimulation of the rat gastric fundus are differentially affected by addition and chelation of Cu2+, suggesting that the nitrergic NANC neurotransmitter in the rat gastric fundus is not an S-nitrosothiol but is more likely to be free nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922751      PMCID: PMC1915940          DOI: 10.1111/j.1476-5381.1996.tb15769.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  Role of nitric oxide in gastrointestinal and hepatic function and disease.

Authors:  M E Stark; J H Szurszewski
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

2.  Differentiation by hydroquinone of relaxations induced by exogenous and endogenous nitrates in non-vascular smooth muscle: role of superoxide anions.

Authors:  A J Hobbs; J F Tucker; A Gibson
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

3.  Release of nitric oxide evoked by nerve stimulation in guinea-pig intestine.

Authors:  N P Wiklund; A M Leone; L E Gustafsson; S Moncada
Journal:  Neuroscience       Date:  1993-04       Impact factor: 3.590

4.  Influence of S-nitrosothiols and nitrate tolerance in the rat gastric fundus.

Authors:  A J Barbier; R A Lefebvre
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Understanding the controversy over the identity of EDRF.

Authors:  M Feelisch; M te Poel; R Zamora; A Deussen; S Moncada
Journal:  Nature       Date:  1994-03-03       Impact factor: 49.962

6.  Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor.

Authors:  S W Kerr; L V Buchanan; S Bunting; W R Mathews
Journal:  J Pharmacol Exp Ther       Date:  1992-10       Impact factor: 4.030

7.  S-nitrosocysteine, but not sodium nitroprusside, produces apamin-sensitive hyperpolarization in rat gastric fundus.

Authors:  K Kitamura; Q Lian; A Carl; H Kuriyama
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

8.  An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus.

Authors:  A Gibson; R Babbedge; S R Brave; S L Hart; A J Hobbs; J F Tucker; P Wallace; P K Moore
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

Review 9.  Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission.

Authors:  K M Sanders; S M Ward
Journal:  Am J Physiol       Date:  1992-03

10.  Biological activity of S-nitrosothiols: the role of nitric oxide.

Authors:  W R Mathews; S W Kerr
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

View more
  4 in total

1.  Influence of redox compounds on nitrovasodilator-induced relaxations of rat coronary arteries.

Authors:  M E Murphy
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries.

Authors:  I L Megson; S Morton; I R Greig; F A Mazzei; R A Field; A R Butler; G Caron; A Gasco; R Fruttero; D J Webb
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

3.  Effects of superoxide anion generators and thiol modulators on nitrergic transmission and relaxation to exogenous nitric oxide in the sheep urethra.

Authors:  A Garcia-Pascual; A Labadia; G Costa; D Triguero
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

4.  Cyclic GMP-associated apamin-sensitive nitrergic slow inhibitory junction potential in the hamster ileum.

Authors:  H Matsuyama; S Thapaliya; T Takewaki
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.